“gilead-sciences” Archives

in
Entry Author Date Location
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic 03/12/20 Boston
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven 03/02/20 San Francisco
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Spring Bank Pharma Ends Hepatitis B Work After Death in Clinical Trial 01/29/20 Boston
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal 12/12/19 Boulder/Denver
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
Looking to Level Up in NASH, Novo Nordisk Licenses Ube Drug Candidate 11/08/19 National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
ArsenalBio Launches With $85M for “Programmable” T Cell Therapies 10/17/19 San Francisco
Enanta Steps Forward in NASH Race, With Unclear Prospects 09/26/19 Boston
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight 08/28/19 New York
New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease 08/22/19 National
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles 07/25/19 Boston
TScan Lands $48M for Better, Safer T-Cell Receptor Cancer Therapies 07/24/19 Boston
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets 07/18/19 San Francisco
Gilead Ups Stake in Galapagos With $5B Deal to Jumpstart Its R&D 07/15/19 San Francisco
Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More 07/05/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field 06/19/19 San Francisco
CymaBay Therapeutics Stumbles in NASH Race, Shares Fall 06/11/19 San Francisco
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
With $120M, AlloVir Faces Big Test of Cell Therapy to Fight Infection 05/22/19 Texas
Page 1 of 13 next page »